Shadan Lalezari

Methylenetetrahydrofolate Reductase Genotypes and Early-Onset Coronary Artery Disease

Aviv Mager, Shadan Lalezari, Tamar Shohat et al. · Circulation · 1999 · 77 citations

Efficacy and safety of BAY 81‐8973, a full‐length recombinant factor VIII: results from the LEOPOLD I trial

Kapil Saxena, Shadan Lalezari, Johannes Oldenburg et al. · Haemophilia · 2016 · 55 citations · Full text

Pharmacokinetic properties of BAY 81‐8973, a full‐length recombinant factor VIII

Anita Shah, Heinz Delesen, Stephen J. Garger et al. · Haemophilia · 2015 · 40 citations

Correlation between endogenous <scp>VWF</scp>:Ag and <scp>PK</scp> parameters and bleeding frequency in severe haemophilia <scp>A</scp> subjects during three‐times‐weekly prophylaxis with rFVIII‐<scp>FS</scp>

Shadan Lalezari, U. Martinowitz, Jerzy Windyga et al. · Haemophilia · 2013 · 39 citations · Full text

BAY 94‐9027, a PEGylated recombinant factor VIII, exhibits a prolonged half‐life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies

Anita Shah, Thomas Coyle, Shadan Lalezari et al. · Haemophilia · 2018 · 39 citations · Full text